INTEGRIN CD103-ROLE IN TH2 PULMONARY IMMUNE RESPONSES
整合素 CD103 在 TH2 肺免疫反应中的作用
基本信息
- 批准号:6655627
- 负责人:
- 金额:$ 13.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:antigen antibody reaction asthma cell differentiation cell migration cytokine dendritic cells enzyme linked immunosorbent assay flow cytometry gene expression helper T lymphocyte hybridomas immunity immunocytochemistry immunoregulation integrins laboratory mouse leukocyte activation /transformation phenotype protein structure function respiratory hypersensitivity single cell analysis tissue /cell culture
项目摘要
Asthma, a disease which affects millions worldwide, represents a complex inflammatory disorder characterized by airway inflammation and airway hyperreactivity. Although multiple molecular signals and cells are involved in the pathogenesis of asthma, the CD4+ T lymphocyte has been clearly shown to play a critical role. Specifically, CD4+ T helper cells which are characterized by the secretion of Th2 cytokines. The immunologic pathways by which naive T helper cells differentiate into a Th2 phenotype, however, have yet to be clearly delineated. Integrin alphaE(CD103)beta7 is expressed on lymphocytes, dendritic cells and mast cells, cell types which have been implicated in asthma and the dynamic regulation of mucosal immune responses. The role of integrin alphaEbeta7 in the mediation of pulmonary allergic inflammation and airway reactivity was studied in an in vivo murine model of airway hyperresponsiveness, characterized by high levels of Th2 cytokines, airway hyperresponsiveness and pulmonary inflammation. Integrin alphaE deficient mice were found to have decreased pulmonary inflammation, airway reactivity and markedly reduced levels of Th2 cytokines. In vitro studies demonstrated unfractionated splenocytes from alphaE deficient mice produced significantly lower levels of Th2 cytokines than alphaE+/+ mice. Mixing studies, using purified populations of splenic CD4+ T cells and accessory cells from alphaE deficient and wild type mice, localized the regulation of CD4+ T cell differentiation to a Th2 phenotype to the accessory cell population. Given that alphaEbeta7 is expressed on 25 percent of splenic dendritic cells, the hypothesis that integrin alphaEbeta7 plays a critical role in the regulation of the phenotypic development of CD4+ T cells, mediated by alphaEbeta7 dendritic cells, was developed. To test this hypothesis, in vitro studies will be performed to demonstrate the role of alphaEbeta7+ dendritic cells in the differentiation of CD4+ T cells to a Th2 phenotype and to characterize their phenotypic and functional characteristics. Adoptive transfer experiments will be performed to determine the ability Of alphaEbeta7+ dendritic cells to mediate Th2 polarization in vivo and to confer airway hyperresponsiveness and pulmonary inflammation in response to aerosolized antigen challenge. The mechanisms by which expression of this integrin on dendritic cells mediates the differentiation of nave T helper cells and Th2 pulmonary immune responses will also be examined. These studies may provide significant insights into the role of integrin alphaEbeta7 in T helper cell differentiation and dendritic cell biology.
哮喘是一种以气道炎症和气道高反应性为特征的复杂炎症性疾病,在全世界影响数百万人。 虽然哮喘的发病机制涉及多种分子信号和细胞,但CD 4 + T淋巴细胞已被明确显示起关键作用。 具体地,CD 4 + T辅助细胞的特征在于分泌Th 2细胞因子。 然而,幼稚T辅助细胞分化为Th 2表型的免疫学途径尚未被清楚地描述。 整合素alphaE(CD 103)beta7在淋巴细胞、树突状细胞和肥大细胞上表达,这些细胞类型与哮喘和粘膜免疫反应的动态调节有关。 在气道高反应性的体内鼠模型中研究了整联蛋白α E β 7在肺变应性炎症和气道反应性的介导中的作用,所述气道高反应性的特征在于高水平的Th 2细胞因子、气道高反应性和肺炎症。 发现整合素α E缺陷小鼠具有降低的肺部炎症、气道反应性和显著降低的Th 2细胞因子水平。 体外研究表明,与alphaE+/+小鼠相比,来自alphaE缺陷小鼠的未分级脾细胞产生显著更低水平的Th 2细胞因子。混合研究,使用纯化的脾CD 4 + T细胞和辅助细胞从alphaE缺陷型和野生型小鼠,定位调节CD 4 + T细胞分化为辅助细胞群体的Th 2表型。 鉴于25%的脾树突状细胞表达α Ebeta 7,提出了整合素α Ebeta 7在α Ebeta 7树突状细胞介导的CD 4 + T细胞表型发育调节中起关键作用的假设。为了检验这一假设,将进行体外研究以证明α E β 7+树突状细胞在CD 4 + T细胞分化为Th 2表型中的作用,并表征其表型和功能特征。将进行连续转移实验以确定α E β 7+树突细胞在体内介导Th 2极化的能力以及响应于雾化抗原攻击而赋予气道高反应性和肺部炎症的能力。 树突状细胞表达整合素介导NA分化的机制还将检查T辅助细胞和Th 2肺免疫应答。这些研究可能为了解整合素alphaE β 7在辅助性T细胞分化和树突状细胞生物学中的作用提供重要见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MANUELA CERNADAS其他文献
MANUELA CERNADAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MANUELA CERNADAS', 18)}}的其他基金
Cathepsins in Antigen Presentation and Lung Immunity
组织蛋白酶在抗原呈递和肺免疫中的作用
- 批准号:
7061391 - 财政年份:2003
- 资助金额:
$ 13.39万 - 项目类别:
Cathepsins in Antigen Presentation and Lung Immunity
组织蛋白酶在抗原呈递和肺免疫中的作用
- 批准号:
6839934 - 财政年份:2003
- 资助金额:
$ 13.39万 - 项目类别:
Cathepsins in Antigen Presentation and Lung Immunity
组织蛋白酶在抗原呈递和肺免疫中的作用
- 批准号:
7174809 - 财政年份:2003
- 资助金额:
$ 13.39万 - 项目类别:
INTEGRIN CD103-ROLE IN TH2 PULMONARY IMMUNE RESPONSES
整合素 CD103 在 TH2 肺免疫反应中的作用
- 批准号:
6388694 - 财政年份:2000
- 资助金额:
$ 13.39万 - 项目类别:
INTEGRIN CD103-ROLE IN TH2 PULMONARY IMMUNE RESPONSES
整合素 CD103 在 TH2 肺免疫反应中的作用
- 批准号:
6774790 - 财政年份:2000
- 资助金额:
$ 13.39万 - 项目类别:
INTEGRIN CD103-ROLE IN TH2 PULMONARY IMMUNE RESPONSES
整合素 CD103 在 TH2 肺免疫反应中的作用
- 批准号:
6191503 - 财政年份:2000
- 资助金额:
$ 13.39万 - 项目类别:
INTEGRIN CD103-ROLE IN TH2 PULMONARY IMMUNE RESPONSES
整合素 CD103 在 TH2 肺免疫反应中的作用
- 批准号:
6526599 - 财政年份:2000
- 资助金额:
$ 13.39万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 13.39万 - 项目类别:
Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
- 批准号:
10637048 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:














{{item.name}}会员




